COX-2 inhibitors belong to a subclass of nonsteroidal anti-inflammatory drugs(NSAIDs). NSAIDs, as competitive inhibitors of cyclooxygenase(COX), impede the enzyme responsible for the bioconversion of arachidonic acid to inflammatory prostaglandins(PGs).